Anupam Dalal - 04 Mar 2025 Form 4 Insider Report for Aadi Bioscience, Inc. (WHWK)

Role: Director
Signature: /s/ Stephen Rodin, as Attorney-in-Fact
Issuer symbol: WHWK
Transactions as of: 04 Mar 2025
Net transactions value: +$3,746,400
Form type: 4
Filing time: 05 Mar 2025, 19:51:57 UTC
Previous filing: 14 Jun 2024
Next filing: 16 Jun 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AADI	Common Stock	Award	$3,746,400	+1,561,000	+84%	$2.40	3,410,402	04 Mar 2025	See footnote	F1
holding	AADI	Common Stock						1,130	04 Mar 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of (i) 2,535,488 shares held by Acuta Capital Fund, LP ("Acuta Capital") and (ii) 874,914 shares held by Acuta Opportunity Fund, LP. ("Acuta Opportunity Fund"). Acuta Capital Partners, LLC ("Acuta Partners") is the general partner of each of Acuta Capital and Acuta Opportunity Fund. The Reporting Person is the Chief Investment Officer and Managing Member of Acuta Partners. The Reporting Person has voting and investment authority over all of the shares held by each of Acuta Capital and Acuta Opportunity Fund. Each of Acuta Partners and the Reporting Person disclaim beneficial ownership of the shares of common stock held by each of Acuta Capital and Acuta Opportunity Fund except to the extent of their pecuniary interest therein.

Content

Consists of (i) 2,535,488 shares held by Acuta Capital Fund, LP ("Acuta Capital") and (ii) 874,914 shares held by Acuta Opportunity Fund, LP. ("Acuta Opportunity Fund"). Acuta Capital Partners, LLC ("Acuta Partners") is the general partner of each of Acuta Capital and Acuta Opportunity Fund. The Reporting Person is the Chief Investment Officer and Managing Member of Acuta Partners. The Reporting Person has voting and investment authority over all of the shares held by each of Acuta Capital and Acuta Opportunity Fund. Each of Acuta Partners and the Reporting Person disclaim beneficial ownership of the shares of common stock held by each of Acuta Capital and Acuta Opportunity Fund except to the extent of their pecuniary interest therein.